These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18239149)

  • 1. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells.
    Lombardi A; Cantini G; Piscitelli E; Gelmini S; Francalanci M; Mello T; Ceni E; Varano G; Forti G; Rotondi M; Galli A; Serio M; Luconi M
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):718-24. PubMed ID: 18239149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium.
    Lombardi A; Cantini G; Mello T; Francalanci M; Gelmini S; Cosmi L; Santarlasci V; Degl'Innocenti S; Luciani P; Deledda C; Annunziato F; Forti G; Galli A; Serio M; Luconi M
    Eur J Cell Biol; 2009 Dec; 88(12):731-42. PubMed ID: 19782427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome-proliferator-activated receptor gamma (PPARgamma) is required for modulating endothelial inflammatory response through a nongenomic mechanism.
    Cantini G; Lombardi A; Borgogni E; Francalanci M; Ceni E; Degl'Innocenti S; Gelmini S; Poli G; Galli A; Serio M; Forti G; Luconi M
    Eur J Cell Biol; 2010 Sep; 89(9):645-53. PubMed ID: 20537761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methimazole inhibits CXC chemokine ligand 10 secretion in human thyrocytes.
    Crescioli C; Cosmi L; Borgogni E; Santarlasci V; Gelmini S; Sottili M; Sarchielli E; Mazzinghi B; Francalanci M; Pezzatini A; Perigli G; Vannelli GB; Annunziato F; Serio M
    J Endocrinol; 2007 Oct; 195(1):145-55. PubMed ID: 17911406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokines (interferon-γ and tumor necrosis factor-α)-induced nuclear factor-κB activation and chemokine (C-X-C motif) ligand 10 release in Graves disease and ophthalmopathy are modulated by pioglitazone.
    Antonelli A; Ferrari SM; Fallahi P; Piaggi S; Paolicchi A; Franceschini SS; Salvi M; Ferrannini E
    Metabolism; 2011 Feb; 60(2):277-83. PubMed ID: 20206950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator activated receptor gamma agonists suppress TNFalpha-induced ICAM-1 expression by endothelial cells in a manner potentially dependent on inhibition of reactive oxygen species.
    Jung Y; Song S; Choi C
    Immunol Lett; 2008 Apr; 117(1):63-9. PubMed ID: 18206249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists.
    Antonelli A; Ferrari SM; Fallahi P; Frascerra S; Piaggi S; Gelmini S; Lupi C; Minuto M; Berti P; Benvenga S; Basolo F; Orlando C; Miccoli P
    Endocr Relat Cancer; 2009 Dec; 16(4):1299-311. PubMed ID: 19755523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone antagonizes vascular endothelial growth factor signaling and nuclear factor of activated T cells activation in cardiac valve endothelium.
    Sander TL; Noll L; Klinkner DB; Weihrauch D; He BJ; Kaul S; Zangwill SD; Tweddell JS; Pritchard KA; Oldham KT
    Endothelium; 2006; 13(3):181-90. PubMed ID: 16840174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosiglitazone increases matrix production and quenches inflammation: studies in human cells.
    Solini A; Santini E; Madec S; Nannipieri M; Bonotti A; Cuccato S; Ferrannini E
    Diabetes Metab Res Rev; 2008; 24(3):197-204. PubMed ID: 17922475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells.
    Desouza CV; Gerety M; Hamel FG
    Vascul Pharmacol; 2009; 51(2-3):162-8. PubMed ID: 19520186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion.
    Hung CF; Huang TF; Chen BH; Shieh JM; Wu PH; Wu WB
    Eur J Pharmacol; 2008 May; 586(1-3):275-82. PubMed ID: 18439578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiazolidinediones inhibit TNFalpha induction of PAI-1 independent of PPARgamma activation.
    Liu HB; Hu YS; Medcalf RL; Simpson RW; Dear AE
    Biochem Biophys Res Commun; 2005 Aug; 334(1):30-7. PubMed ID: 15990085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
    Ho AW; Wong CK; Lam CW
    Immunobiology; 2008; 213(7):533-44. PubMed ID: 18656701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional down-regulation of human alpha(2A)-adrenoceptors by IFNgamma and TNFalpha in intestinal cells.
    Cayla C; Schaak S; Crassous PA; Buffin-Meyer B; Delage C; Paris H; Senard JM; Denis C
    Eur J Pharmacol; 2008 Jun; 588(1):33-40. PubMed ID: 18457828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARγ agonist suppresses TLR4 expression and TNF-α production in LPS stimulated monocyte leukemia cells.
    Wang CZ; Zhang Y; Li XD; Hu Y; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ; Liu PQ; Liu JJ
    Cell Biochem Biophys; 2011 Jul; 60(3):167-72. PubMed ID: 21104157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroid enhances TNF-alpha-mediated leukocyte adhesion to pulmonary microvascular endothelial cells.
    Matsuda A; Orihara K; Fukuda S; Fujinaga H; Matsumoto K; Saito H
    Allergy; 2008 Dec; 63(12):1610-6. PubMed ID: 19032233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 15-Deoxy-12,14-prostaglandin J2 inhibits interferon gamma induced MHC class II but not class I expression on ARPE cells through a PPAR gamma independent mechanism.
    Willermain F; Dulku S; Gonzalez NS; Blero D; Driessens G; De Graef C; Caspers L; Bruyns C
    Prostaglandins Other Lipid Mediat; 2006 Sep; 80(3-4):136-43. PubMed ID: 16939878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression.
    Sun DI; Nizamutdinova IT; Kim YM; Cai XF; Lee JJ; Kang SS; Kim YS; Kang KM; Chai GY; Chang KC; Kim HJ
    Int Immunopharmacol; 2008 Sep; 8(9):1272-81. PubMed ID: 18602074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation.
    Huang NL; Chiang SH; Hsueh CH; Liang YJ; Chen YJ; Lai LP
    Int J Cardiol; 2009 May; 134(2):169-75. PubMed ID: 18597869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cell-based anti-inflammatory effects of rosiglitazone.
    Sottili M; Filardi T; Cantini G; Cosmi L; Morano S; Luconi M; Lenzi A; Crescioli C
    J Endocrinol Invest; 2022 Jan; 45(1):105-114. PubMed ID: 34170488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.